The global prevalence of Diabetes Mellitus (DM) has experienced a significant surge over the past two decades, escalating from approximately 30 million cases in 1985 to a staggering 177 million cases in 2000. The rise of DM is attributed, in part, to sedentary lifestyles. In India, it is projected that around 79.4 million individuals may be affected by Diabetes Mellitus by the year 2030. Amidst this growing health concern, Homoeopathy has emerged as an essential therapeutic modality, offering organ-specific medicines in the form of mother tinctures. This clinical study focuses on individuals with Diabetes Mellitus Type 2 within the age group of 30-75 years. A total of 32 patients, comprising both pre-diagnosed and newly diagnosed DM cases, were enrolled in the study. Among them, 30 patients, comprising both male and female participants, successfully completed the study, while two individuals dropped out during the research. The study assessed the impact of Homoeopathic treatment on Fasting, Post-prandial blood sugar levels, and HbA1c levels. The experimental group, consisting of 30 patients who received medication, experienced notable improvements in 23 cases. However, in seven cases, no significant improvement was observed. The medicine employed for treatment was Cephalandra Indica in tincture form, chosen for its recognized antidiabetic properties. The findings of this study contribute to the growing body of evidence supporting the efficacy of Homoeopathy as an adjunctive therapeutic approach for Diabetes Mellitus Type 2. Further research and larger-scale studies are warranted to validate these outcomes and explore the full potential of Homoeopathy in managing this widespread chronic disorder.